CliffBio
small molecule

PROTONIX

PANTOPRAZOLE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyWyeth →See this company's full patent-cliff portfolio

Drug detail

Brand namePROTONIX
Active ingredientPANTOPRAZOLE SODIUM
StrengthEQ 20MG BASE
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2001
Marketing statusRX

More from Wyeth

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.